
Do Epidural Steroid Injections Add Meaningful Benefit for Lumbar Spinal Stenosis?
Do Epidural Steroid Injections Add Meaningful Benefit for Lumbar Spinal Stenosis?
Leg pain, heaviness, or fatigue that builds with standing or walking—and eases with sitting or leaning forward—can fit lumbar spinal stenosis. But an MRI showing a narrow spinal canal does not, by itself, prove that stenosis is the pain generator. The history, neurologic examination, walking pattern, and imaging still need to agree before any procedure is considered.
What question did the best-known randomized trial ask?
The 2014 LESS trial enrolled 400 adults age 50 or older who had central lumbar spinal stenosis on MRI or CT, plus moderate-to-severe leg pain and disability. Investigators randomized 200 people to glucocorticoid plus lidocaine and 200 to lidocaine alone. Participants received one or two fluoroscopically guided epidural injections before the primary evaluation at six weeks. The two co-primary outcomes were disability on the 24-point Roland–Morris Disability Questionnaire (RMDQ) and leg pain on a 0–10 scale.[1]
This comparison matters: the trial tested whether adding steroid improved outcomes beyond lidocaine. It did not include a sham-injection group, so it could not determine how either injection compared with no injection.[1]
Did adding steroid improve the primary outcomes?
At six weeks, the steroid-plus-lidocaine group did not have a statistically significant advantage over lidocaine alone:
- Disability: adjusted between-group difference −1.0 RMDQ point (95% CI, −2.1 to 0.1; P=0.07).
- Leg pain: adjusted between-group difference −0.2 point (95% CI, −0.8 to 0.4; P=0.48).[1]
Both groups improved from baseline, but without a sham group that shared improvement cannot be assigned to the injection itself. Placebo effects, regression to the mean, the natural course of symptoms, contact with study staff, and lidocaine are all possible explanations.[1]
Small differences at three weeks favored steroid plus lidocaine, but the investigators judged them clinically insignificant, and they were not present at six weeks. The injection approach—interlaminar or transforaminal—was chosen by the treating physician rather than randomized, so the trial cannot establish that one approach is superior.[1]
What were the tradeoffs and limitations?
One or more adverse events were reported by 21.5% of participants receiving steroid plus lidocaine and 15.5% receiving lidocaine alone; this difference was not statistically significant (P=0.08). The average number of events per participant was higher with steroid (0.29 versus 0.17; P=0.02). Serious events were rare. Cortisol suppression was more common at three and six weeks after steroid-containing injections, consistent with systemic steroid exposure.[1]
Important limitations include the active comparator rather than a sham injection, only six weeks of primary follow-up, nonrandomized choice of injection approach, and variation in steroid type and dose. The results apply to the studied population with central stenosis and should not be generalized to every cause of back or leg pain.
What does newer pooled evidence add?
A 2025 American Academy of Neurology systematic review evaluated randomized trials of epidural steroids for radiculopathy and spinal stenosis. For lumbar stenosis, the reviewers concluded that epidural steroid injections might modestly reduce disability, but probably do not reduce short-term pain; evidence was insufficient for long-term pain. The short-term disability estimate had low confidence and substantial heterogeneity (I²=86%), so its reported number needed to treat should not be read as a precise prediction for an individual patient.[2]
An earlier 2015 systematic review found no clear benefit for spinal stenosis, while noting that the stenosis evidence base was small and many trials had methodological limitations. Its findings for radiculopathy were different and should not be substituted for stenosis evidence.[3]
How should this evidence guide a treatment decision?
An epidural injection is not a diagnostic shortcut and does not make surgery inevitable. A careful decision starts by asking:
- Do the symptoms fit neurogenic claudication or another nerve-root pattern?
- Does the examination show a concordant neurologic finding or another likely pain source?
- Does imaging identify narrowing at a level that matches the clinical pattern?
- Have lower-risk options—activity modification, an individualized exercise or therapy plan, and appropriate medications—been considered?
- Is there a specific, time-limited goal, such as improving walking tolerance enough to participate in rehabilitation?
For a selected patient, an injection may be considered as a limited therapeutic trial after weighing diabetes control, infection risk, bone health, other steroid exposure, and the uncertain size and duration of benefit. The response should be reassessed using function as well as pain—not repeated automatically.
Progressive weakness, new bowel or bladder dysfunction, saddle numbness, or other rapidly changing neurologic symptoms require prompt medical evaluation rather than a routine injection pathway.
The throughline is simple: identify the pain generator, match symptoms and examination to imaging, and choose the least invasive treatment that is appropriate for the clinical problem.
Sources
- Friedly JL, Comstock BA, Turner JA, et al. A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis. New England Journal of Medicine. 2014;371:11–21. Randomized, double-blind trial. https://www.nejm.org/doi/full/10.1056/NEJMoa1313265
- Armon C, Narayanaswami P, Potrebic S, et al. Epidural Steroids for Cervical and Lumbar Radicular Pain and Spinal Stenosis: Systematic Review Summary. Neurology. 2025. AAN guideline-subcommittee systematic review of randomized trials. https://pubmed.ncbi.nlm.nih.gov/39938000/
- Chou R, Hashimoto R, Friedly J, et al. Epidural Corticosteroid Injections for Radiculopathy and Spinal Stenosis: A Systematic Review and Meta-analysis. Annals of Internal Medicine. 2015;163:373–381. https://pubmed.ncbi.nlm.nih.gov/26302454/
This educational material is general information, not individual medical advice.


































